{"id":"https://openalex.org/W4362543040","doi":"https://doi.org/10.1158/2159-8290.22528635","title":"Supplementary Figure 2 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition","display_name":"Supplementary Figure 2 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362543040","doi":"https://doi.org/10.1158/2159-8290.22528635"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.22528635","doi":"https://doi.org/10.1158/2159-8290.22528635","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.22528635","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PI3K_Inhibition_Impairs_BRCA1_2_Expression_and_Sensitizes_BRCA-Proficient_Triple-Negative_Breast_Cancer_to_PARP_Inhibition/22528635/1/files/39991641.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PI3K_Inhibition_Impairs_BRCA1_2_Expression_and_Sensitizes_BRCA-Proficient_Triple-Negative_Breast_Cancer_to_PARP_Inhibition/22528635/1/files/39991641.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109602405","display_name":"Yasir H. Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasir H. Ibrahim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055956240","display_name":"Celina Garc\u00eda-Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celina Garc\u00eda-Garc\u00eda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073423716","display_name":"Violeta Serra","orcid":"https://orcid.org/0000-0001-6620-1065","observed_orcids":["https://orcid.org/0000-0001-6620-1065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Violeta Serra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100317887","display_name":"Lei He","orcid":"https://orcid.org/0000-0002-8615-5673","observed_orcids":["https://orcid.org/0000-0002-8615-5673"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lei He","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044563807","display_name":"Kristine Torres\u2010Lockhart","orcid":"https://orcid.org/0000-0002-2124-9214","observed_orcids":["https://orcid.org/0000-0002-2124-9214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristine Torres-Lockhart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089513581","display_name":"Aleix Prat","orcid":"https://orcid.org/0000-0003-2377-540X","observed_orcids":["https://orcid.org/0000-0003-2377-540X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleix Prat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112265098","display_name":"Pilar Ant\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pilar Anton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021550037","display_name":"Patricia Cozar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Cozar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085170830","display_name":"Marta Guzm\u00e1n","orcid":"https://orcid.org/0000-0002-0924-9887","observed_orcids":["https://orcid.org/0000-0002-0924-9887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Guzm\u00e1n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028333558","display_name":"Judit Grueso","orcid":"https://orcid.org/0000-0003-1093-7940","observed_orcids":["https://orcid.org/0000-0003-1093-7940"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judit Grueso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004195561","display_name":"Olga Rodr\u00edguez","orcid":"https://orcid.org/0000-0003-0511-5176","observed_orcids":["https://orcid.org/0000-0003-0511-5176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga Rodr\u00edguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024682199","display_name":"Mar\u00eda Teresa Calvo","orcid":"https://orcid.org/0000-0003-2583-2199","observed_orcids":["https://orcid.org/0000-0003-2583-2199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Teresa Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112498455","display_name":"Claudia Monica Aura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia Aura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000177058","display_name":"Orland D\u0131\u0301ez","orcid":"https://orcid.org/0000-0001-7339-0570","observed_orcids":["https://orcid.org/0000-0001-7339-0570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Orland D\u00edez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036020728","display_name":"Isabel Teresa Rubio","orcid":"https://orcid.org/0000-0003-0035-0679","observed_orcids":["https://orcid.org/0000-0003-0035-0679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabel T. Rubio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090108117","display_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-4238-2046","observed_orcids":["https://orcid.org/0000-0003-4238-2046","https://orcid.org/0009-0004-2204-2014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 P\u00e9rez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031165814","display_name":"Jordi Ahnert Rodon","orcid":"https://orcid.org/0000-0001-6467-3632","observed_orcids":["https://orcid.org/0000-0001-6467-3632","https://orcid.org/0000-0003-2234-5248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordi Rod\u00f3n","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052735318","display_name":"Leif William Ellisen","orcid":"https://orcid.org/0000-0003-0444-7910","observed_orcids":["https://orcid.org/0000-0003-0444-7910"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leif W. Ellisen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002819777","display_name":"Maurizio Scaltriti","orcid":"https://orcid.org/0000-0002-5522-1447","observed_orcids":["https://orcid.org/0000-0002-5522-1447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maurizio Scaltriti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Baselga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.9980000257492065},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibition","display_name":"PARP inhibition","score":0.8840000033378601},{"id":"https://openalex.org/keywords/transcriptional-repression","display_name":"transcriptional repression","score":0.546999990940094},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7888206243515015},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6131279468536377},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5919241309165955},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5791115164756775},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5659669637680054},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5354830026626587},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.49137821793556213},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4060420095920563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3099512457847595},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3023582994937897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30086272954940796},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.12396037578582764},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.11411574482917786},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08070835471153259},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07390981912612915},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06638339161872864}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2159-8290.22528635","doi":"https://doi.org/10.1158/2159-8290.22528635","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.22528635","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PI3K_Inhibition_Impairs_BRCA1_2_Expression_and_Sensitizes_BRCA-Proficient_Triple-Negative_Breast_Cancer_to_PARP_Inhibition/22528635/1/files/39991641.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2159-8290.22528635.v1","doi":"https://doi.org/10.1158/2159-8290.22528635.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22528635.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22528635","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PI3K_Inhibition_Impairs_BRCA1_2_Expression_and_Sensitizes_BRCA-Proficient_Triple-Negative_Breast_Cancer_to_PARP_Inhibition/22528635","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.22528635","doi":"https://doi.org/10.1158/2159-8290.22528635","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2159-8290.22528635","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_PI3K_Inhibition_Impairs_BRCA1_2_Expression_and_Sensitizes_BRCA-Proficient_Triple-Negative_Breast_Cancer_to_PARP_Inhibition/22528635/1/files/39991641.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362543040.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2130084494","https://openalex.org/W4392702518","https://openalex.org/W2601622979","https://openalex.org/W2793785533","https://openalex.org/W2093927675","https://openalex.org/W2078572393","https://openalex.org/W2059620499","https://openalex.org/W3133484936","https://openalex.org/W4200527153","https://openalex.org/W2258601828"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"208K,":[3],"PI3K":[4],"blockade":[5],"suppresses":[6],"BRCA1/2":[7],"transcription":[8]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}